Ramya Auroprem is an associate in Axinn’s intellectual property group. Her practice focuses on patent litigation in district courts and Section 337 Investigations at the International Trade Commission. Ramya has handled matters involving 3G/4G cellular communications standards, cloud technology, and on behalf of both originator and generic pharmaceutical clients.
Prior to joining Axinn, Ramya was a judicial extern for the Hon. Elizabeth D. Laporte in the United States District Court for the Northern District of California and a research assistant for Prof. Andrea Chandrasekher. She holds a BS in Chemical Biology from the University of California, Berkeley and served as an Executive Editor of the UC Davis Law Review, President of the King Hall Intellectual Property Law Association, and a member of the King Hall Moot Court Honors Board.
Professional Activities
- South Asian Bar Association, Northern California Chapter
- Asian Pacific American Bar Association, Silicon Valley Chapter
Experience
- Defense of Thales against the patent infringement action brought by Philips relating to 3G and 4G LTE wireless communication technology.
- Representing Google in various investigations of its business practices in the U.S. and other jurisdictions.
- Assisted pro bono client in obtaining a favorable settlement of civil rights claims.
- Successfully secured asylum on behalf of multiple pro bono clients.
Thought Leadership
- A Mid-Year Check-In: The First Five Months of the Federal Circuit’s 2024 Precedential Rulings, IPWatchdog, June 18, 2024
- Potential Shifts in Section 337 Precedent: What The Data Tells Us, IPWatchdog, May 13, 2024
- How the U.S. Supreme Court Affected the Lives of U.S. IP Lawyers in 2023, IAM, December 29, 2023
- Would Congress' Proposed ITC Reforms Thwart NPEs?, Law360, May 26, 2023
- Federal Circuit Reverses Course on ‘Appropriate Deference’ in Indefiniteness Determinations, Bloomberg Law, January 5, 2023
- The Uncertain Future of Patent Indefiniteness Under Federal Circuit's Deference Standard, Bloomberg Law, May 6, 2022
- Axinn IP Update: Federal Circuit Confirms That AAPA Cannot Be the Basis for IPRs, But Leaves the “Basis” Determination Question Open, Axinn Update, February 3, 2022
- New U.S. Legislation Creates Momentum for Biosimilars, BioProcess Online, June 25, 2021
- FDA's Longtime Approach to New Chemical Entity Designations Now Codified, Outsourced Pharma and Pharmaceutical Online, June 14, 2021
Education
- JD – University of California, Davis School of Law (2020)
- BS – University of California, Berkeley (2017)
Admissions
- California
- U.S. District Court Central District of California
- U.S. District Court Northern District of California
- U.S. District Court Western District of Texas